Hirotaka Suto

Akashi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Therapeutic Strategy Concerns for BRAF V600E-Mutated Differentiated Thyroid Cancer.

Therapeutic Strategy Concerns for BRAF V600E-Mutated Differentiated Thyroid Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 06, 2026

Efficacy of S-1 Monotherapy for Salivary Duct Carcinoma With MYC Amplification.

Efficacy of S-1 Monotherapy for Salivary Duct Carcinoma With MYC Amplification.

Journal: In vivo (Athens, Greece)

Published: April 03, 2026

Trastuzumab Deruxtecan in Gastric Cancer.

Trastuzumab Deruxtecan in Gastric Cancer.

Journal: The New England journal of medicine

Published: October 01, 2025

Perioperative Pembrolizumab in Head and Neck Cancer.

Perioperative Pembrolizumab in Head and Neck Cancer.

Journal: The New England journal of medicine

Published: September 17, 2025

Optimal Sunitinib Dosing Based on Platelet Count in an Older Patient With Gastrointestinal Stromal Tumor.

Optimal Sunitinib Dosing Based on Platelet Count in an Older Patient With Gastrointestinal Stromal Tumor.

Journal: In vivo (Athens, Greece)

Published: September 01, 2025

Acute esophageal mucosal injury during pembrolizumab treatment after a hypopharyngeal cancer patient's free jejunal autograft reconstruction, as an immune-related adverse event.

Acute esophageal mucosal injury during pembrolizumab treatment after a hypopharyngeal cancer patient's free jejunal autograft reconstruction, as an immune-related adverse event.

Journal: International cancer conference journal

Published: May 05, 2025

Resumption of Immune Checkpoint Inhibitor Therapy Following Immune-related Adverse Events.

Resumption of Immune Checkpoint Inhibitor Therapy Following Immune-related Adverse Events.

Journal: In vivo (Athens, Greece)

Published: April 08, 2025

Low-dose Imatinib Efficacy in a Gastrointestinal Stromal Tumor Patient With KIT Exon 11 W557_K558 Deletion.

Low-dose Imatinib Efficacy in a Gastrointestinal Stromal Tumor Patient With KIT Exon 11 W557_K558 Deletion.

Journal: In vivo (Athens, Greece)

Published: October 10, 2024

Role of the Hippo-YAP/TAZ Pathway in Epithelioid Hemangioendothelioma and its Potential as a Therapeutic Target.

Role of the Hippo-YAP/TAZ Pathway in Epithelioid Hemangioendothelioma and its Potential as a Therapeutic Target.

Journal: Anticancer research

Published: July 13, 2024

Confirmatory diagnosis and successive chemotherapeutic treatments of metastatic skeletal EWSR1::NFATC2 sarcoma: A case report.

Confirmatory diagnosis and successive chemotherapeutic treatments of metastatic skeletal EWSR1::NFATC2 sarcoma: A case report.

Journal: Oncology letters

Published: July 09, 2024

Long-term survival of a patient with gastric cancer with bone marrow metastasis receiving S-1 plus oxaliplatin beyond three years: a case report and literature review.

Long-term survival of a patient with gastric cancer with bone marrow metastasis receiving S-1 plus oxaliplatin beyond three years: a case report and literature review.

Journal: Frontiers in oncology

Published: June 14, 2024

Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.

Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.

Journal: Endocrine journal

Published: January 31, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026